有治疗性化脓性关节炎病史的患者在全关节置换术后假体周围感染风险高
这项多中心回顾性分析纳入62例有同关节治疗性天然化脓性关节炎病史后行初次全髋或全膝关节置换的患者,假体周围感染(PJI)发生5例(8%),Kaplan-Meier无PJI生存率在14.5±1.14年时为92%;所有PJI均发生于全膝关节置换患者,吸烟与PJI风险升高相关(HR 8.06;95%CI 1.33-48.67;p=0.023)。
要点
- 同关节治疗性天然化脓性关节炎病史患者全关节置换后PJI发生率为8%(5/62)。
- 所有PJI均发生于全膝关节置换患者,全髋与全膝无PJI生存率比较p=0.068。
- 吸烟与PJI风险升高相关(HR 8.06;95%CI 1.33-48.67;p=0.023)。
核心结论
- 有天然关节感染病史的患者PJI风险较高,尤其是吸烟者。
- 作者认为应仔细评估其他因素,包括允许从天然化脓性关节炎消退到全关节置换至少间隔2年。
- 作者认为行全膝关节置换的患者似乎更易发生PJI,可能受益于更积极的规划。
- 作者认为对可能带来额外风险的合并症(如糖尿病)进行内科优化在这些患者中变得格外重要。
研究设计与样本
- 多中心回顾性分析,纳入2000年1月至2016年12月间接受初次全髋或全膝关节置换且有同关节治疗性天然化脓性关节炎病史的患者。
- 患者仅在术前评估认为关节感染已消退时才纳入,评估包括无活动性感染或局部关节炎症的临床症状和体征、近期平片仅显示晚期退变而无活动性骨溶解或骨感染证据、术前感染实验室检查(红细胞沉降率、C反应蛋白和总白细胞计数)在正常范围内。
- 最终队列包括62例患者,从全关节置换时起平均随访4.4年(范围3个月至17年)。
- 21例(34%)随访不足2年,包括6例(10%)死亡;研究期间共8例(13%)死亡,无一例因PJI死亡。
- 采用Kaplan-Meier分析估计所有全关节置换及全髋与全膝置换患者的总体生存率,并使用Mantel-Cox对数秩检验进行统计比较;采用Cox回归风险比(HR)生存分析识别PJI危险因素;计算化脓性关节炎后2年内行全关节置换患者的PJI比值比(OR)作为额外的时间分析。
主要发现
- 有同关节治疗性天然化脓性关节炎病史的患者中,PJI比例为5/62(8%)。
- Kaplan-Meier分析显示,在14.5±1.14年(95%CI 12.3-16.8年)时无PJI总体生存率为92%。
- 所有PJI病例仅发生于行全膝关节置换的患者,单独分析时10.5±0.9年(95%CI 8.7-12.3年)生存率为85%,而行全髋关节置换的患者为100%(p=0.068)。
- PJI发生平均时间为10个月(范围2-20个月)。
- 在控制年龄、性别、受累关节和合并症等相关混杂变量后,发现吸烟与PJI发生风险升高相关(HR 8.06;95%CI 1.33-48.67;p=0.023)。
临床怎么用
- 作者认为在这些患者中应仔细评估其他因素,包括允许从天然化脓性关节炎消退到全关节置换至少间隔2年。
- 作者认为行全膝关节置换的患者似乎更易发生PJI,可能受益于更积极的规划。
- 作者认为对可能带来额外风险的合并症(如糖尿病)进行内科优化在这些患者中变得格外重要。
局限性
- 21例(34%)随访不足2年,包括6例(10%)死亡。
- 尽管存在局限性,本研究建议仔细评估这些患者的其他因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In patients undergoing total joint arthroplasty (TJA), increasing attention has been directed recently toward identifying specific patient-related risk factors that may predispose patients to periprosthetic joint infection (PJI). Currently, it is unclear whether having a history of a treated native septic arthritis is a risk factor for PJI after TJA in the same joint. Previous studies have reported contradictory evidence and results varied between a substantially higher rates of PJIs to very low or no reported PJIs. QUESTIONS/PURPOSES: (1) What is the risk of PJI in patients who received TJA and had a history of treated same-joint native joint septic arthritis and (2) What are the associated risk factors for these patients developing PJI? METHODS: This was a multicenter retrospective analysis of patients who received primary THA or TKA between January 2000 and December 2016 and who had a history of treated native joint septic arthritis in the same joint. Patients were included in the study only if they were considered to have resolved their joint infection based on a preoperative evaluation that included: (1) the absence of clinical symptoms and signs of active infection or local joint inflammation, (2) recent plain radiographs showing only advanced degenerative changes without evidence of active osteolysis or bone infection, (3) preoperative laboratory investigations for infection, including erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and total leukocyte counts within normal ranges. Patients were reviewed for the occurrence of postoperative PJI. The final cohort included 62 patients who had a mean followup of 4.4 years (range, 3 months-17 years) from the time of TJA. A total of 21 patients (34%) had less than 2 years of followup, including six (10%) mortalities. In total, eight patients (13%) died during the study period, none of which were due to PJI. Patient characteristics, time interval from treatment of septic arthritis to TJA, and Charlson comorbidity index adjusted for age were collected. We used a Kaplan-Meier analysis to estimate the overall survivorship among all TJAs as well as those who underwent THA versus TKA, and we performed a statistical comparison using the Mantel-Cox log-rank test. We performed a Cox regression hazard ratio (HR) survival analysis to identify risk factors for PJI. The PJI odds ratios (OR) for patients who underwent TJA within 2 years of septic arthritis were calculated as an additional temporal analysis. RESULTS: In patients with a history of treated same-joint native septic arthritis, the proportion of PJI was five of 62 patients (8%). The Kaplan-Meier analysis demonstrated an overall survivorship free from PJI of 92% at 14.5 ± 1.14 years (95% confidence interval [CI] = 12.3-16.8 years). All PJI cases occurred only in patients who underwent TKA, which when analyzed separately, yielded a survivorship of 85% at 10.5 ± 0.9 years (95% CI = 8.7-12.3 years) versus 100% in patients who underwent THA (p = 0.068). Mean time to PJI occurrence was 10 months (range, 2-20 months). After controlling for relevant confounding variables, such as age, sex, affected joint and comorbidities, we found smoking (HR, 8.06; 95% CI, 1.33-48.67; p = 0.023) to be associated with increased risk for PJI development. CONCLUSION: Patients with history of native joint infections are at higher risk of PJI, especially smokers. Despite our limitations, this study suggests careful assessment of several other factors in these patients, including allowing a minimum interval of 2 years from the time of resolving native joint septic arthritis to TJA. Patients who are undergoing TKA seem to be more prone to the PJI risk and may benefit from more aggressive planning. In addition, medical optimization of comorbidities that may confer additional risk, such as diabetes, become exceptionally important in these patients. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Sultan AA, Mahmood B, Samuel LT, et al. Patients with a History of Treated Septic Arthritis are at High Risk of Periprosthetic Joint Infection after Total Joint Arthroplasty. Clin Orthop Relat Res. 2019. PMID: 30913112. doi:10.1097/CORR.0000000000000688
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。